ABSTRACT
INTRODUCTION
Ethical dilemmas in research since time immemorial have been a major concern for researchers worldwide.
The question "what makes clinical research ethical" is significant and difficult to answer as multiple factors are involved. With the enormous amount of literature and guidelines available online, it becomes very tricky to follow the right ones. The basic ethical principles are autonomy, justice, beneficence, and nonmalfeasance for research. The current ethical principles assess the risk-benefit ratio of the clinical trial so that the results can be generalized and extrapolated to the population as a whole. 1 The regulations unique to the country of research are mandatory to follow. Table 1 lists few important ethical guidelines that a researcher and ethics committee member should be aware of. [2] [3] [4] [5] [6] [7] The Indian Council of Medical Research 7 has proposed ethical guidelines for Biomedical
Research in India. The majority of the guidelines explicitly mention about the clinical trial using the newly found drug for human participants and any intervention, such as drugs, surgical procedures, preventive measures, lifestyle modifications, devices, educational or behavioral treatment, and rehabilitation strategies. In academic institutions, the protocol has to meet various screening stages as shown in Flow Chart 1 before assessment of ethics committee.
REGULATIONS IN INDIAN PERSPECTIVE
In India, it is mandatory to take ethical clearance for a clinical trial on human participants from a registered ethical committee under Rule 122DD and informed consent according to 
FUNCTIONS AND FORMATION OF THE ETHICS COMMITTEE IN INDIA
• The institutional ethics committee has to prepare a constitution, standard operating procedures, conditions for member appointment, the offices, and the quorum requirements. The committee should inform in writing to the licensing authority in case of any changes in the ethics committee. Licensing authority has the right to issue show cause notice in the event of any complaints and wrongdoing. The authority has the right to cancel the registration of the committee.
• Ethics committee should have a minimum of 7 mem bers and a maximum of 15 members, which includes a chairperson (independent of an institution or outside the institution), one member secretary, clinicians (medical and scientific), legal expert, social scientist, and layperson. • There should be no conflict of interest while decision making on the research protocol from any of the committee members. All members should declare their conflict of interest.
• The committee can invite specialist and experts in the case of discussion related to the topic of their expertise, but the invited experts will not have the right of voting.
RESPONSIBILITIES OF ETHICS COMMITTEE
• The novelty of research and social value: The study should add to the existing knowledge or should help in innovation for the new knowledge and should benefit the society and humanity by enlarge.
• Scientifically sound: The research should be scientifically valid sound study design, appropriate statistical analysis, the feasibility of the study, and precise scientific objective.
• Fair selection of the study samples: Selection of the vulnerable group for research with risky outcomes is a major ethical problem. Appropriate selection of the sample based on the merit of the study and justice to the sample is of most importance.
• Favorable risk-benefit ratio: Maximum benefit and minimum risk care should be taken to have minimal risk to the patient in comparison to the benefit. The benefit is assessed on the total good from the research to the individual and the society. Patients should not be exploited.
• Independent review of the research protocol: Review of the protocol for possible conflict of interest, the source of funding, and other financial details are to be thoroughly assessed. There should also be review of research design of the trial and risk to the population recruited in the trial.
• Informed consent: It should be taken from every sample recruited in the study; it should be voluntary, legal, and comprehending and should be recorded and maintained as per regulations of the country.
• Respect for potential and enrolled participants in the study:
Autonomy of the participants involved in research is very crucial; the participants need to be informed of the risk and benefits involved in the trial, and they have the right to withdraw from the study at any given time.
AUDIOVISUAL INFORMED CONSENT
The clinical trials on new drugs have strict regulations in India; Drug & Cosmetic Rule 1945 being amended from time to time under Schedule Y of the rules. The clinical trials are to be conducted with approved protocols, and the Good Clinical Practice Guidelines published by CDSCO and Directorate General of Health Services, Government of India. 9 Honorable Supreme Court of India, CDSCO vide F. No. GCT/20/SC/Clin./2013 DCG1 dated November 19, 2013, has categorically stated that all clinical trials will have to follow AV consent in addition to the written informed consent. The statement should clearly explain the study participants about the purpose of research, duration, the procedure/intervention involved, the possible risk involved, benefit to the participant, referrals in case of emergency, and compensation to the study participants. The investigator should maintain confidentiality regarding the participants involved in the trial. The consent has to be explained in the language the patient understands the best, in simple and not technical words. The consent has to be understood, voluntary, and the participant has the right to withdraw from the study anytime.
METHOD OF RECORDING
The investigator will identify the participant involved, the language they understand, and protocol of the study. A study team member can help as interpreter if the language is not known. The photo ID of the participant is documented to identify the participant. The video camera for the AV recording should be of adequate capability to simultaneously capture the facial details of the participant, impartial witness (if any), and investigator/ authorized person present during the consent process. The AV recording should be conducted in a room conducive to the recording of disturbance-free audio and video of the consent process. During the videography process, care should also be taken not to include unrelated persons/patients at the hospital within the field of vision. Poor video or audio quality may not sever the purpose of consent; care should be taken to use the camera with good resolution and mic with good quality. The AV recordings of consent have to be preserved for a minimum period of 5 years after the completion of the study.
LATEST UPDATES
• No permission for conduct of clinical trial intended for academic purposes with respect to approved drug formulation shall be required for any new indication or new route of administration or new dose or new dosage form where the trial is approved by the ethics committee, the data generated are not intended for submission to the licensing authority. The ethics committee, however, has to inform the licensing authority about the study updates.
12,13
• The participants have to be notified about the intervention failure regarding therapeutic effect in the clinical trial involving new drugs.
• The participants should be disclosed about placebo controlled trials that placebo administered will not have any therapeutic effect.
CONCLUSION
In the current scenario, researchers and ethics committees have to keep track of the changes in the rules, regulations, and amendments as this is a dynamic process. There can be more seminars and workshops to discuss the updates and latest guidelines. With the number of clinical trials increasing, there will be more complex ethical issues to handle and to learn from different situations. The CDSCO is providing with all updates on their website.
CLINICAL SIGNIFICANCE
The review comes handy for clinical researchers and ethics committee members in academic institutions to check on the current updates and keep abreast with the knowledge on regulations of ethics in India.
